Medical Yoga for Patients With Stress-related Symptoms

The purpose of this study is to compare the effect of Medical Yoga as a group treatment, to conventional treatment provided by a physical therapist, for people with perceived stress-related symptoms.

Forty people are to be randomized to either:

1. Intervention Group - Medical Yoga, group treatment for eight weeks, 60 minutes per week, with the guidance of a physical therapist.

   or

2. Control - treatment as usual (TAU) in physical therapy.

Study Overview

• Status: Completed
• Conditions: Stress-related Illness/Anxiety
• Intervention / Treatment: Other: Medical Yoga; Other: Treatment as Usual (physical therapy)

• Study Type: Interventional
• Enrollment (Actual): 45
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Sweden
  • Gothenburg, Sweden
    • Närhälsan Gibraltar Rehabmottagning

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 100 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Perceived stress and anxiety, which could be expressed as for example as tension in the neck and shoulders, insomnia, anxiety and headaches.

Exclusion Criteria:

• Do not understand Swedish (as group instructions need to be understood),
• Pregnancy,
• Psychotic symptoms,
• Ongoing or physical therapy treatment the last three months,
• Previously participated in Medical Yoga group.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Medical Yoga; Medical Yoga Group therapy for eight weeks, 60 minutes per week, with the guidance of a physical therapist.	Other: Medical Yoga
Active Comparator: Treatment as Usual (physical therapy); Treatment as Usual provided by physical therapist	Other: Treatment as Usual (physical therapy)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Perceived Stress Scale (PSS)	Outcome will be measured as change between baseline and follow-ups and between follow-ups. Total score will also be analysed between groups at follow-up(s).	baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session

Secondary Outcome Measures

Outcome Measure	Time Frame
Hospital Anxiety and Depression Scale (HADS)	baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session
Health-related quality of Life; EQ5D	baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session
Thorax excursion: Measured in centimeters with tape measure, chest size at the level of processus xiphoideus, the difference between the maximum inhalation and exhalation is registered	baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session
Health-related quality of Life; EQ-VAS	baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session

Collaborators and Investigators

• Sponsor: Maria Larsson

Study record dates

Study Major Dates

• Study Start: September 1, 2016
• Primary Completion (Actual): February 15, 2019
• Study Completion (Actual): March 4, 2019

Study Registration Dates

• First Submitted: September 9, 2016
• First Submitted That Met QC Criteria: September 19, 2016
• First Posted (Estimate): September 20, 2016

Study Record Updates

• Last Update Posted (Actual): September 16, 2020
• Last Update Submitted That Met QC Criteria: September 13, 2020
• Last Verified: September 1, 2020

More Information

Terms related to this study

• Other Study ID Numbers: VGFOUGSB-602221